ArticleNature communications2026
Wireless light-gated photoelectrochemical microneedle wearables for zero-bias longitudinal monitoring in interstitial fluid.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Wearable chemical sensors could enable continuous health monitoring, but long-term measurements in interstitial fluid are limited by power consumption, electrochemical interference and signal drift during wear. Here we show a light-gated photoelectrochemical microneedle wearable for zero-bias chemical monitoring in subcutaneous interstitial fluid. The device combines a swelling-tolerant conductive hydrogel microneedle array, a plasmon-enhanced photoelectrode and a miniaturized module for light excitation, current recording and Bluetooth transmission. Visible light drives oxygen-mediated redox chemistry without an applied bias, reducing interfering electrochemical reactions and power demand. Using uric acid as a representative analyte, the wearable provides wireless readout under hydration and mechanical deformation. In vivo disease-model validation was performed in male rats and mice, where the device tracked uric acid dynamics in chronic kidney disease, diabetic hyperuricemia and bacterial treatment, with trends correlating with blood measurements. This light-gated microneedle architecture offers a modular route for longitudinal monitoring of interstitial-fluid chemistry.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.